Reeve Emma 4
4 · PTC THERAPEUTICS, INC. · Filed Jan 6, 2026
Insider Transaction Report
Form 4
Reeve Emma
Director
Transactions
- Award
Common Stock
2026-01-02+4,000→ 10,666 total - Exercise/Conversion
Common Stock
2026-01-05$46.54/sh+734$34,160→ 11,400 total - Sale
Common Stock
2026-01-05$76.00/sh−734$55,784→ 10,666 total - Award
Stock Option (Right to Buy)
2026-01-02+3,475→ 3,475 totalExercise: $76.74Exp: 2036-01-01→ Common Stock (3,475 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2026-01-05−734→ 0 totalExercise: $46.54Exp: 2035-01-02→ Common Stock (734 underlying)
Footnotes (4)
- [F1]Restricted stock units granted on January 2, 2026 that vest over one year, with five-twelfths (5/12) of the shares underlying the RSUs vesting on June 2, 2026 and the remaining seven-twelfths (7/12) of the original shares underlying the RSUs vesting on January 2, 2027.
- [F2]This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on March 4, 2025.
- [F3]This option was granted on January 2, 2026 and vests over one year in twelve equal monthly installments, commencing on February 2, 2026.
- [F4]Currently exercisable.